Medimir Systems is thrilled to announce that it has successfully raised 5,000,000 in funding, marking a significant milestone in its mission to empower physicians with cutting-edge software solutions. As a pioneering Software Ecosystem that enables expert decision making in any medical field, Medimir Systems combines innovative technology with expert medical content. This funding will propel the development and launch of the highly anticipated single-user version, further enhancing the ease-of-use and efficiency of clinical decision support at the point of care. Medimir’s platform has already proven its worth in rigorous clinical trials at renowned institutions like University Hospital Frankfurt and Heidelberg, with impressive outcomes published in the Journal of Clinical Anesthesia. The infusion of capital will not only accelerate product enhancements and feature rollouts—such as automated documentation, discharge documents, and advanced communication tools—but also expand ongoing clinical studies in collaboration with partners like Charité Berlin, Fraunhofer Mevis, TU München, RWTH Aachen, University Hospital Würzburg, University Hospital Frankfurt, and Asklepios Clinic Hamburg. With full CE-certification (MDR, Class 2a) under its belt, Medimir Systems is committed to driving significant cost reductions, improving workflow, and ensuring high-quality, guideline-conformant medical care. A carve-out of Börm Bruckmeier Verlag GmbH, a company with a 30-year heritage in expert medical publishing and guideline applications, Medimir Systems continues to build on a legacy trusted by institutions such as the Robert Koch Institut, the NHS, and over 40 medical associations, as well as industry leaders like Pfizer, Novartis, Boehringer Ingelheim, Roche, and Sanofi. This funding marks an exciting new chapter in Medimir’s journey towards revolutionizing clinical decision support globally.








